Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-19-049117

President & CEO bought 5,000 shares at $43.63 ($218,150)

From the SEC's structured data for this filing

Trades in this filing

KAKKIS EMIL D · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-09-11 Purchase : show line 1 in the form +5,000 $43.63 $218,150 472,479 D
Open-market purchases · 5,000 sh · avg $43.63 · $218,150
Loading xslF345X03/doc4.xml…